The Effect of Mandala Painting on Anxiety in Coronary Heart Patients

• ClinicalTrials.gov Identifier: NCT05307224
• Recruitment Status: Completed
• First Posted: April 1, 2022
• Last Update Posted: September 25, 2023
• Sponsor: Marmara University
• Information provided by (Responsible Party): Gülşah Çamcı, Marmara University

Study Description

Brief Summary:

This study was planned as a randomized controlled trial to determine the effect of mandala painting on the anxiety of coronary heart patients.

Condition or disease	Intervention/treatment	Phase
Coronary Artery Disease; Anxiety	Device: Mandala	Not Applicable

Detailed Description:

Patients in the control group will receive routine care.Patiens in the experimental group will receive routine care and mandala painting. Experimental group will paint mandala for 30 minutes/day in the evenings for six consecutive days. In order not to interrupt the duties of the nurse and doctor in the clinic, it was planned for the experimental group to paint mandalas in the evening. Six pre-selected mandalas were planned to be printed separately on A4 paper. Each patient will be given a new mandala each day. At the beginning of the study, six colors will be given to the experimental group (yellow, blue, green, red, purple, brown). It was planned to do it for 6 days, as it was found that painting mandala for more than a week in the studies could reduce the patient's attention. In addition, based on the average hospitalization days of the patients, reaching patients for more than a week will be a problem.

Study Design

• Study Type: Interventional (Clinical Trial)
• Actual Enrollment: 60 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Intervention Model Description: control group (usual care) and experimental group (mandala painting)
• Masking: Single (Participant)
• Masking Description: It was planned to use block randomization for the random assignment of patients to the experimental and control groups.
• Primary Purpose: Prevention
• Official Title: The Effect of Mandala Painting on Anxiety in Coronary Heart Patients: A Randomized Controlled Trial
• Actual Study Start Date: August 9, 2023
• Actual Primary Completion Date: August 9, 2023
• Actual Study Completion Date: September 23, 2023

Arms and Interventions

Arm	Intervention/treatment
Experimental: intervention group; In the experimental group, patients will receive both routine care and mandala painting. Experimental group will paint mandala for 30 minutes/day in the evening for six consecutive days.	Device: Mandala; Experimental group will paint mandala for 30 minutes/day in the evenings for six consecutive days. Six pre-selected mandalas were planned to be printed separately on A4 paper. Each patient will be given a new mandala each day. Additionally, At the beginning of the study, the experimental group will be given six colors (yellow, blue, green, red, purple, brown).; Other Name: Mandala Painting
No Intervention: control group; The control group will receive the usual care.

Outcome Measures

Primary Outcome Measures :

1. The Hospital Anxiety and Depression Scale [ Time Frame: six days ]
   The scale consists of 14 items including 7 anxiety and 7 depression questions. Responses are in the form of a four-point likert. Each item is scored between 0 and 3, and the cut-off points of the scale were found to be 10 for the anxiety subscale and 7 for the depression subscale. Individuals who score above these scores are considered at risk. The scoring score of each item in the scale is different, and the 1st, 3rd, 5th, 6th, 8th, 10th, 11th and 13th items show that the severity is gradually decreasing and its scoring is 3, 2, 1, 0. The 2nd, 4th, 7th, 9th, 12th and 14th items of the scale are scored as 0, 1, 2, 3. Items 1, 3, 5, 7, 9, 11, and 13 for the anxiety subscale, and items 2, 4, 6, 8, 10, 12, and 14 for the depression subscale. The scores of the items are summed. The lowest zero and the highest 21 points can be obtained from both sub-dimensions of the scale.

Eligibility Criteria

• Ages Eligible for Study: 18 Years to 85 Years (Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

• Having agreed to participate in the research/approved the informed consent form
• No visual or hearing impairment
• Hospitalization due to Coronary Heart Disease (patients hospitalized with the diagnosis of acute coronary syndromes such as stable angina, unstable angina, myocardial infarction, percutaneous coronary intervention and stent implantation),
• Being over 18 years old,
• Being at least literate
• The absence of any problem that would prevent him/her from painting mandala (no problem in his arm or hand that would prevent his movement (such as paralysis, or the presence of a catheter on the hand), no serious illness)
• Must not have a diagnosis of mental illness/anxiety disorder

Exclusion Criteria:

• Control group patients who coincided with the same room as the intervention group, by randomization.
• Patients who want to quit the study voluntarily during the study
• Patients whose general condition deteriorates (such as altered hemodynamics or consciousness)

Contacts and Locations

Locations

Turkey

Marmara University

Istanbul, Turkey

Sponsors and Collaborators

Marmara University

Investigators

• Principal Investigator: Gülşah Çamcı, PhD; Marmara University

More Information

• Responsible Party: Gülşah Çamcı, Assistant Prof, Marmara University
• ClinicalTrials.gov Identifier: NCT05307224
• Other Study ID Numbers: MU-SBF-IHH-GC-02
• First Posted: April 1, 2022
• Last Update Posted: September 25, 2023
• Last Verified: September 2023

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: No

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Gülşah Çamcı, Marmara University:

Coronary Artery Disease; Anxiety; mandala

Additional relevant MeSH terms:

Coronary Artery Disease; Myocardial Ischemia; Coronary Disease; Anxiety Disorders; Mental Disorders; Heart Diseases; Cardiovascular Diseases; Arteriosclerosis; Arterial Occlusive Diseases; Vascular Diseases